The effect of COVID-19 restriction on metabolic syndrome in primary hypertension.
Ayça Burcu KahramanPelin Pekçetin Şişikİsmail Eray ÇelikBahar BüyükkaragözPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2022)
COVID-19 restrictions were associated with an increased risk of parameters associated with metabolic syndrome in patients with primary hypertension. Physicians should carefully monitor the weight, blood pressure, fasting plasma glucose level, and total cholesterol levels in patients during periods of movement/activity restrictions such as during the COVID-19 pandemic.
Keyphrases
- blood pressure
- metabolic syndrome
- coronavirus disease
- blood glucose
- sars cov
- insulin resistance
- hypertensive patients
- heart rate
- uric acid
- primary care
- body mass index
- cardiovascular risk factors
- weight loss
- respiratory syndrome coronavirus
- physical activity
- weight gain
- cardiovascular disease
- adipose tissue
- body weight